AGIO
AGIOS PHARMACEUTICALS, INC.
Latest Form 4:Sale$914KbyGheuens Sarah (Chief Medical Officer) · filed Aug 6, 2026
AGIOS PHARMACEUTICALS, INC. (AGIO) has 41 SEC Form 4 filings (98 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Aug 6, 2026.
The most active filer is Chief Medical Officer Gheuens Sarah with 8 filings. Insiders have net sold $3.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Brian Goff
- Employees:486
- HQ:Cambridge, MA, US
- IPO:2013-07-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.2M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 30,000 | $914K | Aug 6 | SEC ↗ | |
| Chief Medical Officer | Sale | 4,007 | $151K | Jul 2 | SEC ↗ | |
| Chief Executive Officer | Sale | 19,068 | $662K | Apr 6 | SEC ↗ | |
| Chief Corp Dev & Strategy | Sale | 2,959 | $103K | Apr 6 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,940 | $102K | Apr 6 | SEC ↗ | |
| Chief Legal Officer | Sale | 3,280 | $114K | Apr 6 | SEC ↗ | |
| Chief Financial Officer | Sale | 3,141 | $109K | Apr 6 | SEC ↗ | |
| Chief Commercial Officer | Sale | 3,262 | $113K | Apr 6 | SEC ↗ | |
Viswanadhan KrishnanFirst filing | Chief Corp Dev & Strategy | Sale | 2,959 | $82K | Mar 9 | SEC ↗ |
| Principal Accounting Officer | Sale | 5,272 | $152K | Mar 5 | SEC ↗ | |
| Chief Financial Officer | Sale | 5,035 | $146K | Mar 3 | SEC ↗ | |
| Chief Legal Officer | Sale | 4,031 | $117K | Mar 3 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,868 | $83K | Mar 3 | SEC ↗ | |
Washburn Theodore James Jr.First in 6 months | Principal Accounting Officer | Sale | 2,223 | $64K | Mar 3 | SEC ↗ |
| Chief Executive Officer | Sale | 18,055 | $523K | Mar 3 | SEC ↗ | |
| Chief Commercial Officer | Sale | 2,868 | $83K | Mar 3 | SEC ↗ | |
| Chief Commercial Officer | Sale | 2,872 | $78K | Jan 7 | SEC ↗ | |
Goff BrianFirst filing | Chief Executive Officer | Sale | 18,703 | $507K | Jan 2 | SEC ↗ |
Jones CeciliaFirst in 3 months | Chief Financial Officer | Sale | 2,932 | $79K | Jan 2 | SEC ↗ |
Burns James WilliamFirst filing | Chief Legal Officer | Sale | 2,932 | $79K | Jan 2 | SEC ↗ |
| Chief Medical Officer | Sale | 2,932 | $79K | Jan 2 | SEC ↗ | |
Milanova TsvetaFirst filing | Chief Commercial Officer | Sale | 2,932 | $79K | Jan 2 | SEC ↗ |
| Director | Sale | 200 | $9K | Nov 14 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,454 | $107K | Nov 13 | SEC ↗ | |
| Chief Medical Officer | Sale | 200 | $9K | Nov 3 | SEC ↗ | |
Gheuens SarahFirst filing | Chief Medical Officer | Sale | 3,302 | $145K | Oct 29 | SEC ↗ |
| Director | Sale | 200 | $8K | Oct 10 | SEC ↗ | |
Scadden DavidFirst filing | Director | Sale | 200 | $8K | Oct 2 | SEC ↗ |
Jones CeciliaFirst filing | Chief Financial Officer | Sale | 3,651 | $134K | Sep 30 | SEC ↗ |
Washburn Theodore James Jr.First filing | Principal Accounting Officer | Sale | 8,546 | $315K | Sep 9 | SEC ↗ |
Related companies
AGIOS PHARMACEUTICALS, INC. is in the Healthcare sector.